Connect with us

Sponsored

Momentum Grows Behind President Trump’s Call To Reschedule Cannabis

Published

on

Two days after cannabis users around the world gathered for their annual day of celebration, some are waking up with a renewed sense of purpose as they add their voices to a bipartisan coalition of nonprofits, patient advocates, and lawmakers pushing President Donald Trump to reclassify marijuana’s controlled substance classification.

For decades, cannabis advocacy groups have operated at the fringes of Washington, D.C. lobbying activity, urging past presidents to downgrade the U.S. Drug Enforcement Agency’s classification of marijuana, which has long been listed as a Schedule I drug alongside heroin, LSD, and other substances considered to be at a much higher risk of abuse.

More recently, President Trump expressed his interest in shifting cannabis to a Schedule III substance, which would allow medical researchers to have greater access to federal funding to explore homeopathic therapies and ancillary benefits of expanded medicinal use among chronically and terminally ill patients. Cannabis is already being used to treat chronic pain and epilepsy, and it has even become recommended for treating post-traumatic stress disorder (PTSD). Rescheduling would allow more medical research on providing treatment options for patients.

Conservatives, meanwhile, have become galvanized in some corners over the prospect of expanded access to cannabis fueling revenue and raising the quality of life within cities and towns around the country. Jeff Brandes, founder of the Florida Policy Project and a Republican former state senator, said reclassification would be both a tangible and totemic victory.

“The move to reschedule cannabis is a clear example of where evidence should lead the way, not outdated research and negative stigma,” he wrote last week in an op-ed to the South Florida Sun Sentinel.

“This change is not just symbolic; it’s a vital step toward correcting a historic wrong and ensuring that marijuana policy is aligned with current scientific understanding. Fortunately, this change has President Donald Trump’s full support and hopefully, we’ll be able to see his administration get this across the finish line.”

During the height of last year’s campaign, President Trump expressed interest in downgrading marijuana to a less highly regulated substance category, a move that he so far appears inclined to keep.

“As President, we will continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug, and work with Congress to pass common sense laws, including safe banking for state authorized companies, and supporting states rights to pass marijuana laws, like in Florida, that work so well for their citizens,” President Trump wrote on Truth Social last fall.

To officially reclassify the substance, Attorney General Pam Bondi could issue a final rule from the Department of Justice; President Trump could also push advocates’ long-awaited change across the finish line with an executive order as soon as this year.

“Today, there is meaningful change finally on the horizon, thanks to President Donald Trump and his leadership in supporting the rescheduling of cannabis from a Schedule I drug to a Schedule III drug,” former Rep. Matt Gaetz (R-FL) wrote in the Tampa Bay Times last month. “I have always believed that marijuana laws should be rooted in science, not stigma.”